Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Folate Receptor-Targeted Diagnostics and Therapeutics for Inflammatory Diseases.

Yi YS.

Immune Netw. 2016 Dec;16(6):337-343. doi: 10.4110/in.2016.16.6.337. Epub 2016 Dec 22. Review.

2.

Cancer stratification by molecular imaging.

Weber J, Haberkorn U, Mier W.

Int J Mol Sci. 2015 Mar 4;16(3):4918-46. doi: 10.3390/ijms16034918. Review.

3.

Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review.

Marchetti C, Palaia I, Giorgini M, De Medici C, Iadarola R, Vertechy L, Domenici L, Di Donato V, Tomao F, Muzii L, Benedetti Panici P.

Onco Targets Ther. 2014 Jul 10;7:1223-36. doi: 10.2147/OTT.S40947. eCollection 2014. Review.

4.

Profile of vintafolide (EC145) and its use in the treatment of platinum-resistant ovarian cancer.

Luyckx M, Votino R, Squifflet JL, Baurain JF.

Int J Womens Health. 2014 Mar 31;6:351-8. doi: 10.2147/IJWH.S39696. eCollection 2014. Review.

6.

Assessment of molecular interactions through magnetic relaxation.

Santiesteban OJ, Kaittanis C, Perez JM.

Angew Chem Int Ed Engl. 2012 Jul 2;51(27):6728-32. doi: 10.1002/anie.201202077. Epub 2012 May 24. No abstract available.

7.
8.

Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects.

Blom HJ, Smulders Y.

J Inherit Metab Dis. 2011 Feb;34(1):75-81. doi: 10.1007/s10545-010-9177-4. Epub 2010 Sep 4. Review.

9.

Genes involved with folate uptake and distribution and their association with colorectal cancer risk.

Figueiredo JC, Levine AJ, Lee WH, Conti DV, Poynter JN, Campbell PT, Duggan D, Lewinger JP, Martinez ME, Ulrich CM, Newcomb P, Potter J, Limburg PJ, Hopper J, Jenkins MA, Le Marchand L, Baron JA, Haile RW.

Cancer Causes Control. 2010 Apr;21(4):597-608. doi: 10.1007/s10552-009-9489-6. Epub 2009 Dec 27.

10.

Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues.

Zhao R, Matherly LH, Goldman ID.

Expert Rev Mol Med. 2009 Jan 28;11:e4. doi: 10.1017/S1462399409000969. Review.

11.

Synthesis and discovery of high affinity folate receptor-specific glycinamide ribonucleotide formyltransferase inhibitors with antitumor activity.

Deng Y, Wang Y, Cherian C, Hou Z, Buck SA, Matherly LH, Gangjee A.

J Med Chem. 2008 Aug 28;51(16):5052-63. doi: 10.1021/jm8003366. Epub 2008 Aug 5.

12.

The reduced folate carrier (RFC) is cytotoxic to cells under conditions of severe folate deprivation. RFC as a double edged sword in folate homeostasis.

Ifergan I, Jansen G, Assaraf YG.

J Biol Chem. 2008 Jul 25;283(30):20687-95. doi: 10.1074/jbc.M802812200. Epub 2008 May 22.

13.

Folic acid transport via high affinity carrier-mediated system in human retinoblastoma cells.

Kansara V, Paturi D, Luo S, Gaudana R, Mitra AK.

Int J Pharm. 2008 May 1;355(1-2):210-9. doi: 10.1016/j.ijpharm.2007.12.008. Epub 2007 Dec 23.

14.
15.

Structure and regulation of a polymorphic gene encoding folate receptor type gamma/gamma'.

Wang H, Ross JF, Ratnam M.

Nucleic Acids Res. 1998 May 1;26(9):2132-42.

16.

Supplemental Content

Support Center